Vietnam Next Generation Sequencing Market Outlook to 2030

Vietnam Next Generation Sequencing Market Overview

• In recent years, the Vietnam Next Generation Sequencing market has experienced substantial growth, this is reflected by the Asia-Pacific Next Generation Sequencing market reached a valuation of USD 1.20 billion in 2023 growing at a CAGR of 24%. 
• The Vietnam Next Generation Sequencing (NGS) market is considered fragmented. Key players in the Vietnam NGS market include Illumina, Thermo Fisher Scientific, BGI Genomics, Roche, and Qiagen.
• In 2023, an important development in the Vietnam NGS market was the launch of a new sequencing platform by BGI Genomics. This platform, designed to deliver faster and more accurate genomic data, has been adopted by several research institutions across Vietnam.

Vietnam Next Generation Sequencing Current Market Analysis

• The impact of NGS on the Vietnamese healthcare sector has been profound, revolutionizing the approach to disease diagnosis and treatment. The ability to sequence entire genomes quickly and cost-effectively has enabled more precise and personalized healthcare solutions.
• The key growth drivers for the Vietnam NGS market include the rising prevalence of chronic diseases and genetic disorders, which has led to increased demand for genomic testing. In 2023, the prevalence of genetic disorders in Vietnam was estimated to affect a substantial portion of the country’s population.
• Ho Chi Minh City has emerged as a dominant region in the Vietnam NGS market, driven by its advanced healthcare infrastructure and concentration of leading research institutions.

Vietnam Next Generation Sequencing Market Segmentation

By Product: The Vietnam NGS market is segmented by product type into Sequencing Instruments, Consumables, and Services. In 2023, Sequencing Instruments dominated the market owing to the continuous advancements in sequencing technology and the increasing demand for high-throughput sequencing platforms in research and clinical applications.

By Application: The market is further segmented by application into Clinical Diagnostics, Drug Discovery, and Research. Clinical Diagnostics dominated the market in 2023 due to its increasing use of NGS in diagnosing genetic disorders, cancer, and infectious diseases drives this segment. The ability to provide comprehensive genomic data for personalized treatment plans makes NGS a valuable tool in clinical settings.

Vietnam Next Generation Sequencing Market Competitive Landscape

Vietnam Next Generation Sequencing Market Analysis

Growth Drivers

• Increasing Prevalence of Genetic Disorders: The Vietnam NGS market is being driven by the rising number of genetic disorders. In 2024, it is estimated that a substantial part of the Vietnamese population will be affected by genetic disorders, creating a significant demand for advanced diagnostic tools such as NGS. This demand is fueling the growth of the market as healthcare providers adopt NGS to deliver accurate and early diagnosis.
• Advancements in NGS Technology: Continuous advancements in NGS technology, such as the development of more efficient sequencing platforms and bioinformatics tools, are driving the market forward. In 2024, a new high-throughput sequencing platform capable of processing thousands of samples simultaneously was introduced, greatly reducing the cost and time required for sequencing.
• Growing Adoption in Clinical Diagnostics: The use of NGS in clinical diagnostics is rapidly increasing in Vietnam. In 2024, over 500 hospitals and clinics in Vietnam are expected to integrate NGS into their diagnostic protocols, particularly for cancer and rare genetic diseases. This widespread adoption is enhancing patient care by providing personalized treatment options based on genomic data.

Market Challenges

• High Cost of Sequencing: Despite technological advancements, the high cost of NGS remains a significant challenge. In 2024, the average cost of a whole genome sequencing test in Vietnam is estimated to be USD 1,000, making it inaccessible to many patients. Efforts to reduce these costs are essential for broader adoption of NGS technologies.
• Lack of Skilled Professionals: The shortage of skilled professionals trained in genomic technologies and bioinformatics poses a challenge to the Vietnam NGS market. In 2024, it is estimated that Vietnam will require additional professionals in this field to meet the growing demand for NGS services and data analysis.
• Data Management and Interpretation: The large volumes of data generated by NGS present challenges in terms of storage, management, and interpretation. In 2024, the average genomic research project in Vietnam is expected to generate over 10 terabytes of data, necessitating robust bioinformatics infrastructure and expertise.

Vietnam Next Generation Sequencing Future Market Outlook

The Vietnam next generation sequencing market is poised for remarkable growth, driven by integration of AI in genomic data analysis, expansion of personalized medicine, and development of cost-effective sequencing solutions.

Market Opportunities

• Integration of AI in Genomic Data Analysis: Over the next five years, the integration of artificial intelligence (AI) in genomic data analysis will revolutionize the Vietnam NGS market. AI-powered tools will enable faster and more accurate interpretation of complex genomic data, enhancing the clinical utility of NGS.
• Expansion of Personalized Medicine: By 2029, the application of NGS in personalized medicine is expected to grow significantly in Vietnam. NGS will be widely used to tailor treatment plans based on individual genetic profiles, improving patient outcomes and reducing healthcare costs.